Stephen C. Rose, PhD                                                                                                      February 27, 2026                  

What if better aging turned out to involve something less glamorous than a moonshot and more glamorous than, say, plain oatmeal? Glycine fits that sort of description. It is a small, ordinary amino acid, and ordinary things in biology sometimes do surprisingly important work. The reason glycine has drawn attention is not that it is mysterious. It is the opposite. It shows up all over the place - in collagen, in glutathione, in neurotransmission, and in metabolic pathways that aging researchers care about. In mice, it has even produced a modest but real lifespan signal. In humans, though, the evidence is still mostly about biomarkers and symptoms, not extra birthdays on the cake. [1]

What Is Glycine?

Glycine is a nonessential amino acid, meaning your body can make it and you also get it from food. [2] That sounds modest, but biology is full of modest-looking molecules doing union-scale work behind the curtain.

A few of glycine's jobs matter especially here:

• Collagen structure: collagen, the body’s most abundant protein, has a repeating pattern requires glycine at every third position - the classic Gly-X-Y motif - which is why collagen is so glycine-rich. [3]
• Nervous system signaling: glycine receptors are major inhibitory receptors in parts of the central nervous system, especially the spinal cord and brainstem. [4]
• Glutathione, a key antioxidant: glutathione includes glycine as one of its three amino-acid components and is central to redox balance. [5]

How much glycine do people typically eat?

Dietary intake varies with protein intake and dietary pattern, but a nutrition review summarizing cohort data places typical intake in the neighborhood of about 1.5 to 3 g per day in many settings. [6] That does not mean most people are deficient. It simply means the average diet does not resemble the multi-gram supplemental dosing often discussed in longevity circles.

Does glycine decline with age?

This is usually stated more confidently than the evidence deserves. Glycine biology appears to be context-dependent: levels and needs may shift with metabolic health, inflammation, diet, and disease state, and different studies do not all point in the same direction. A more careful summary is that glycine status is often linked to metabolic dysfunction and may become functionally limiting in specific circumstances. [1,7]

Why Glycine Might Matter for Aging Biology

The scientific case for glycine is best framed as a set of plausible mechanisms with varying degrees of support, not as a tidy little miracle story. Biology rarely cooperates with tidy little miracle stories. [1]

1) Overlap with methionine-restriction biology

Methionine restriction - lowering methionine, a sulfur-containing amino acid, while maintaining overall nutrition - extends lifespan in rodent models and remains one of the more durable dietary interventions in aging research. [8-10] Glycine may intersect with sulfur amino acid metabolism and related signaling in ways that partly overlap with methionine-restriction physiology. That is a reasonable hypothesis. It is not yet a settled mechanism. [1,10]

2) Methionine and homocysteine: the common mix-up

This is where a lot of popular writing gets slippery. Methionine supplementation or methionine loading can raise plasma homocysteine in humans. [11] But the cleaner nutritional lever for lowering homocysteine is betaine, also called trimethylglycine, which lowers homocysteine in controlled human studies and can blunt methionine-load effects. [12] So glycine belongs in the conversation, but betaine is the more direct actor when the topic is homocysteine.

3) Glutathione and oxidative stress

Glutathione synthesis requires glycine. [5] In older adults, a controlled study found that providing cysteine plus glycine restored glutathione synthesis and reduced oxidative-stress markers, suggesting that precursor supply can become limiting in some people. [13] The important nuance is that the strongest human evidence here is for combined precursor strategies, not for the claim that glycine alone reliably boosts glutathione across the board. [13]

4) Inflammation and inflammaging

Chronic low-grade inflammation is widely discussed as part of aging biology and often goes by the memorable name inflammaging. [14] Glycine has shown anti-inflammatory and cell-protective effects in several experimental settings, which makes it biologically interesting. [15] That still falls short of proving that glycine supplementation slows human aging. Interesting is not the same thing as settled.

5) Mitochondria via heme synthesis

Glycine is a substrate in heme biosynthesis, and heme is required for proteins that include mitochondrial electron transport chain components. [16] Mitochondrial dysfunction also sits squarely inside mainstream frameworks such as the hallmarks of aging. [17] That gives glycine a plausible connection to energy metabolism and aging biology, though plausible connections do not cash out automatically into clinical benefit.

Animal Studies: Why Glycine Became a Longevity Candidate

The strongest lifespan evidence comes from the National Institute of Aging (NIA) Interventions Testing Program, which runs parallel experiments across multiple sites to improve reproducibility. That matters because a single exciting mouse study can be a little like a brilliant one-hit wonder: memorable, but not always dependable.

In a 2019 Aging Cell paper, dietary glycine supplementation increased median lifespan - the age at which half the animals have died - in genetically heterogeneous mice, with single-digit percent improvements and a somewhat stronger signal in males in some analyses. [18] That is not a dramatic fountain-of-youth result. It is, however, real enough to keep the subject alive.

One detail that deserves to stay attached to every retelling is dose context. The protocol used 8% glycine in the diet. [18] That is a large amount and not something that translates neatly into a simple human-equivalent dose. If that sentence disappears, the story starts sounding far more practical than the data justify.

Animal work also reports glycine effects in models of metabolic dysfunction and liver disease biology, supporting the idea that glycine may influence systemic physiology across more than one pathway. [19,20]

The Human Evidence: Promising Markers, Not Lifespan

Here is the cleanest summary: there are no human trials showing that glycine extends lifespan, and there are no definitive healthspan-extension trials either. What we do have are shorter studies looking at biomarkers and symptoms.

• Type 2 diabetes: glycine treatment has been reported to improve A1C and shift inflammatory markers in a clinical study. [21]
• Metabolic syndrome: a randomized trial using 15 g/day for 3 months reported reductions in oxidative-stress markers and certain cardiovascular-related changes, including systolic blood pressure in men. [22]
• Sleep: 3 g before bedtime has been reported to improve subjective sleep quality and correlate with polysomnographic changes in people with sleep complaints. [23]

Those are meaningful outcomes. Better glycemic control, lower oxidative stress markers, and better sleep are not trivial. They are simply not the same thing as demonstrating a longevity effect.

The Path Forward: How Researchers Evaluate Longevity Candidates

Human lifespan trials are slow, expensive, and logistically nasty. So aging research usually works with a tiered strategy instead.

Biomarkers and surrogate endpoints

A biomarker is a measurable biological signal, such as fasting insulin or C-reactive protein. A surrogate endpoint is a biomarker used as a stand-in for a direct clinical benefit - how someone feels, functions, or survives - and regulators treat surrogate endpoints cautiously because they need validation. [24] The National Institute on Aging has explicitly discussed the challenge of endpoint selection in geroscience-oriented development. [25]

Epigenetic aging clocks

These clocks use DNA methylation patterns to estimate biological age. Several are associated with mortality risk and health outcomes in cohort studies. [26-29] That makes them useful research tools. It does not mean that nudging a clock score guarantees a longer life. If only biology were that polite.

Healthspan trials

Many geroscience trials focus on function - mobility, frailty, quality of life, or incident disease events - because those outcomes are feasible on realistic timelines and matter directly to people. That is where a compound like glycine would ultimately need to prove that it does more than move lab values around.

Safety and Dosing: What Is Fair to Say

Safety

Glycine is common in the diet and is generally well tolerated in many studies, but natural does not mean consequence-free. Hemlock is natural too; nature is not a credential.

Fifteen grams per day for 3 months has been used in metabolic syndrome trials. [22]

Very high doses, about 0.8 g/kg/day, have been used in schizophrenia research and were described as tolerated in that setting, though that does not establish broad, long-term safety for general use. [30]

The fair summary is that short- to medium-term tolerability looks reasonably good in several contexts, but long-term high-dose use for longevity remains under-studied.

Typical research dosing ranges

These are study doses, not recommendations:

• Sleep studies: about 3 g before bedtime. [23]
• Metabolic and inflammation studies: often around 15 g/day, typically divided. [21,22]

There is no established anti-aging dose in humans, and mouse-to-human extrapolations should be treated as informed guesswork, not evidence-based prescriptions.

A Careful Note on Cancer

There is real biology linking glycine pathways to proliferation in some cancer models. One widely cited metabolomics paper connected glycine consumption and pathway activity with rapid cancer cell proliferation across cell lines. [31] But the story is not one-dimensional. Other work suggests that serine, not glycine, may be the limiting input for one-carbon metabolism and proliferation in certain cancer contexts. [32]

So the cautious conclusion is not 'glycine causes cancer' and not 'no possible issue here.' It is that there is a theoretical concern worth respecting, especially for long-term high-dose use, but it has not been established that glycine supplementation increases cancer risk in humans. [31,32]

Bottom Line

Glycine is a credible simple-molecule candidate in longevity science because it has a multi-site mouse lifespan signal, plausible links to aging-relevant biology, and early human data touching metabolic, oxidative-stress, and sleep-related outcomes. [1,18,21-23]

What it does not yet have is definitive proof of human healthspan or lifespan extension. For now, glycine belongs in the category of 'worth taking seriously, not worth overselling.' In longevity science, that is actually a respectable place to be.

References

[1] Johnson AA, Cuellar TL. Glycine and aging: Evidence and mechanisms. Ageing Res Rev. 2023;87:101922. doi:10.1016/j.arr.2023.101922.

[2] Razak MA, Begum PS, Viswanath B, Rajagopal S. Multifarious beneficial effect of nonessential amino acid, glycine: A review. Oxid Med Cell Longev. 2017;2017:1716701. doi:10.1155/2017/1716701.

[3] Shoulders MD, Raines RT. Collagen structure and stability. Annu Rev Biochem. 2009;78:929-958. doi:10.1146/annurev.biochem.77.032207.120833.

[4] Dutertre S, Becker CM, Betz H. Inhibitory glycine receptors: An update. J Biol Chem. 2012;287(48):40216-40223. doi:10.1074/jbc.R112.408229.

[5] Lu SC. Glutathione synthesis. Biochim Biophys Acta. 2013;1830(5):3143-3153. doi:10.1016/j.bbagen.2012.09.008.

[6] Alves A, Bassot A, Bulteau AL, Pirola L, Morio B. Glycine metabolism and its alterations in obesity and metabolic diseases. Nutrients. 2019;11(6):1356. doi:10.3390/nu11061356.

[7] Yan-Do R, Duong E, Manning Fox JE, et al. Impaired glycemia-linked glycine biology in type 2 diabetes and potential mechanisms. Endocrinology. 2017;158(5):1064-1073.

[8] Orentreich N, Matias JR, DeFelice A, Zimmerman JA. Low methionine ingestion by rats extends life span. J Nutr. 1993;123(2):269-274. doi:10.1093/jn/123.2.269.

[9] Miller RA, Buehner G, Chang Y, et al. Methionine-deficient diet extends mouse lifespan, slows immune and lens aging. Aging Cell. 2005;4(3):119-125. doi:10.1111/j.1474-9726.2005.00152.x.

[10] Lee BC, Kaya A, Gladyshev VN. Methionine restriction and life-span control. Ann N Y Acad Sci. 2016;1363:116-124. doi:10.1111/nyas.12973.

[11] Ditscheid B, Fuenfstueck R, Busch M, et al. Effect of L-methionine supplementation on plasma homocysteine. Eur J Clin Nutr. 2005.

[12] Steenge GR, Verhoef P, Katan MB. Betaine supplementation lowers plasma homocysteine in healthy men and women. J Nutr. 2003;133(5):1291-1295. doi:10.1093/jn/133.5.1291.

[13] Sekhar RV, Patel SG, Guthikonda AP, et al. Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. Am J Clin Nutr. 2011;94(3):847-853. doi:10.3945/ajcn.110.003483.

[14] Franceschi C, Bonafe M, Valensin S, et al. Inflamm-aging: An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908:244-254. doi:10.1111/j.1749-6632.2000.tb06651.x.

[15] Zhong Z, Wheeler MD, Li X, et al. L-glycine: A novel antiinflammatory, immunomodulatory, and cytoprotective agent. Curr Opin Clin Nutr Metab Care. 2003;6(2):229-240. doi:10.1097/00075197-200303000-00013.

[16] Ajioka RS, Phillips JD, Kushner JP. Biosynthesis of heme in mammals. Biochim Biophys Acta. 2006;1763(7):723-736. doi:10.1016/j.bbamcr.2006.05.005.

[17] Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153(6):1194-1217. doi:10.1016/j.cell.2013.05.039.

[18] Miller RA, Harrison DE, Astle CM, et al. Glycine supplementation extends lifespan of male and female mice. Aging Cell. 2019;18(3):e12953. doi:10.1111/acel.12953.

[19] El-Hafidi M, Franco M, Ramirez AR, et al. Glycine increases insulin sensitivity and glutathione biosynthesis and protects against oxidative stress in a model of sucrose-induced insulin resistance. Oxid Med Cell Longev. 2018;2018:2101562. doi:10.1155/2018/2101562.

[20] Rom O, Liu Y, Liu Z, et al. Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome. Sci Transl Med. 2020;12(572):eaaz2841. doi:10.1126/scitranslmed.aaz2841.

[21] Cruz M, Maldonado-Bernal C, Mondragon-Gonzalez R, et al. Glycine treatment decreases proinflammatory cytokines and increases interferon-gamma in patients with type 2 diabetes. J Endocrinol Invest. 2008;31(8):694-699. doi:10.1007/BF03346417.

[22] Diaz-Flores M, Cruz M, Duran-Reyes G, et al. Oral supplementation with glycine reduces oxidative stress in patients with metabolic syndrome, improving their systolic blood pressure. Can J Physiol Pharmacol. 2013;91(10):855-860. doi:10.1139/cjpp-2012-0341.

[23] Yamadera W, Inagawa K, Chiba S, Bannai M, Takahashi M, Nakayama K. Glycine ingestion improves subjective sleep quality in human volunteers, correlating with polysomnographic changes. Sleep Biol Rhythms. 2007. doi:10.1111/j.1479-8425.2007.00262.x.

[24] U.S. Food and Drug Administration. Surrogate endpoint resources for drug and biologic development. FDA. Updated July 24, 2018.

[25] National Institute on Aging. Information on FDA review of geroscience-related IND applications. NIA. Published October 22, 2024.

[26] Horvath S, Raj K. DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nat Rev Genet. 2018;19(6):371-384. doi:10.1038/s41576-018-0004-3.

[27] Levine ME, Lu AT, Quach A, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging (Albany NY). 2018;10(4):573-591.

[28] Lu AT, Quach A, Wilson JG, et al. DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging (Albany NY). 2019;11(2):303-327. doi:10.18632/aging.101684.

[29] Marioni RE, Shah S, McRae AF, et al. DNA methylation age of blood predicts all-cause mortality in later life. Genome Biol. 2015;16:25. doi:10.1186/s13059-015-0584-6.

[30] Heresco-Levy U, Javitt DC, Ermilov M, et al. Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia. Arch Gen Psychiatry. 1999;56(1):29-36. doi:10.1001/archpsyc.56.1.29.

[31] Jain M, Nilsson R, Sharma S, et al. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science. 2012;336(6084):1040-1044. doi:10.1126/science.1218595.

[32] Labuschagne CF, van den Broek NJF, Mackay GM, et al. Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells. Cell Rep. 2014;7(4):1248-1258. doi:10.1016/j.celrep.2014.04.045.